Home > Income Statement > OXYGENTA PHARMACEUTICAL

OXYGENTA PHARMACEUTICAL
Revenue

    Back to Income Statement
OXYGENTA PHARMACEUTICAL is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for OXYGENTA PHARMACEUTICAL
Please provide your vote to see the results

OXYGENTA PHARMACEUTICAL Last 5 Year Revenue History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹40 Cr₹31 Cr₹6,052,481 Cr₹52 Cr₹14 Cr

What is the latest Revenue of OXYGENTA PHARMACEUTICAL ?

The latest Revenue ratio of OXYGENTA PHARMACEUTICAL is ₹40 Cr based on Mar2025 Standalone results.
Year Revenue
Mar2025₹40 Cr
Mar2024₹31 Cr
Mar2023₹6,052,481 Cr
Mar2022₹52 Cr
Mar2021₹14 Cr

How is Revenue of OXYGENTA PHARMACEUTICAL Trending?

Years Revenue % Change
Mar2025 ₹40 Cr
27.93
Mar2024 ₹31 Cr
-100.00
Mar2023 ₹6,052,481 Cr
11,633,245.46
Mar2022 ₹52 Cr
279.32
Mar2021 ₹14 Cr -

Compare Revenue of peers of OXYGENTA PHARMACEUTICAL

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL ₹179.4 Cr 1.6% -7.7% -60.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹446,924.0 Cr -0.3% 3.4% 12.7% Stock Analytics
DIVIS LABORATORIES ₹174,619.0 Cr -2.5% -1.2% -1.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹156,450.0 Cr 2.4% 5.2% 47.2% Stock Analytics
CIPLA ₹118,361.0 Cr 2.2% 4.8% -3% Stock Analytics
DR REDDYS LABORATORIES ₹113,253.0 Cr 4.3% 4.1% 4.5% Stock Analytics


OXYGENTA PHARMACEUTICAL Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL

1.6%

-7.7%

-60.3%

SENSEX

-0.8%

0.8%

-7.2%


You may also like the below Video Courses